Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells

Epidermal growth factor receptor (EGFR) and activin A are both overexpressed in oral cavity squamous cell carcinoma (OSCC). We evaluated their clinical correlation and activin A-mediated EGFR regulation in this study. Overexpression of both transcripts/proteins indicated a poorer prognosis in OSCC patients. Knockdown of endogenous INHBA repressed the expression of EGFR and inhibited activin A-mediated canonical Smads, noncanonical phosphorylation of AKT (ser473) (p-AKT ser473) and SP1. Inhibition of PI3K signaling via its inhibitor attenuated p-AKT ser473 and in turn reduced SP1 and EGFR expression in the presence of recombinant activin A (rActivin A) in OSCC cells, as revealed via a luciferase assay and western blotting. However, canonical Smad signaling repressed the EGFR promoter, as revealed by a luciferase assay. The transcription factor SP1, its coactivator CBP/p300, and Smad proteins were recruited to the EGFR proximal promoter following rActivin A treatment, as revealed by chromatin immunoprecipitation (ChIP). Smad2/3/4 dramatically outcompeted SP1 binding to the EGFR proximal promoter following mithramycin A treatment. Activin A activates the PI3K and Smad pathways to compete for binding to overlapping SP1 consensus sequences on the EGFR proximal promoter. Nevertheless, canonical p-Smad2 was largely repressed in OSCC tumor tissues, suggesting that the activin A-mediated noncanonical pathway is essential for the carcinogenesis of OSCC.

• Publication year

  2019

• Venue

  Scientific Reports

• Publication date

  2019-03-26

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/s41598-019-41396-7PMID 30914776PMCID 6435638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials

  2018cited by this paper
• Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1

  2018cited by this paper
• TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways

  2018cited by this paper
• Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis

  2017cited by this paper
• APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism

  2017cited by this paper
• Pro-inflammatory cytokine-driven PI3K/Akt/Sp1 signalling and H2S production facilitates the pathogenesis of severe acute pancreatitis

  2017cited by this paper
• Influence of TGF-β1 on tumor transition in oral cancer cell and BMSC co-cultures.

  2017cited by this paper
• Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma

  2015cited by this paper
• Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells

  2015cited by this paper
• Impact of perineural invasion as independent prognostic factor for local and regional failure in oral squamous cell carcinoma.

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.

  2015cited by this paper
• PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions

  2015cited by this paper
• Oral Cavity Cancer: Risk Factors, Pathology, and Management

  2015cited by this paper
• Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.

  2015cited by this paper
• Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography and Activin A May Predict Mortality in Patients with Carcinoid Intestinal Disease

  2015cited by this paper
• Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer

  2014cited by this paper
• Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases.

  2014cited by this paper
• Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors

  2014cited by this paper
• Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK-ERK Signaling Pathway.

  2014cited by this paper
• Comparative Phosphoproteomic Analysis of Checkpoint Recovery Identifies New Regulators of the DNA Damage Response

  2013cited by this paper
• The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

  2013cited by this paper
• Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells

  2013cited by this paper
• Activin A regulates growth of gastro‐intestinal epithelial cells by mediating epithelial‐mesenchymal interaction

  2013cited by this paper
• Mechanism for activation of mutated epidermal growth factor receptors in lung cancer

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Cyclooxygenase‐2 up‐regulates CCR7 expression via AKT‐mediated phosphorylation and activation of Sp1 in breast cancer cells

  2013cited by this paper
• Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model.

  2013cited by this paper
• Targeting the TGFβ signalling pathway in disease

  2012cited by this paper
• Activins and activin antagonists in the prostate and prostate cancer.

  2012cited by this paper
• The bright and the dark sides of activin in wound healing and cancer

  2012cited by this paper
• Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.

  2012cited by this paper
• TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers

  2012cited by this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cited by this paper
• Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis.

  2011cited by this paper
• Activin B Promotes Epithelial Wound Healing In Vivo through RhoA-JNK Signaling Pathway

  2011cited by this paper
• Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer

  2011cited by this paper
• TIEG1 Inhibits Breast Cancer Invasion and Metastasis by Inhibition of Epidermal Growth Factor Receptor (EGFR) Transcription and the EGFR Signaling Pathway

  2011cited by this paper
• Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A.

  2011cited by this paper
• IGFBP‐2 Expression in MCF‐7 Cells is Regulated by the PI3K/AKT/mTOR Pathway through Sp1 Induced Increase in Transcription

  2010cited by this paper
• Overexpression of Activin A in Oral Squamous Cell Carcinoma: Association with Poor Prognosis and Tumor Progression

  2010cited by this paper
• TGFβ signalling: a complex web in cancer progression

  2010cited by this paper
• Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients

  2010cited by this paper
• The biology of activin: recent advances in structure, regulation and function.

  2009cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Up-regulation of inflammatory signalings by areca nut extract and role of cyclooxygenase-2 -1195G>a polymorphism reveal risk of oral cancer.

  2008cited by this paper
• Recent advances in Oral Oncology.

  2007cited by this paper
• Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response

  2006cited by this paper
• Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells.

  2005cited by this paper
• A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

  2005cited by this paper
• Review of epidermal growth factor receptor biology.

  2004cited by this paper
• Inhibin/activin and ovarian cancer.

  2004cited by this paper
• Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1.

  2004cited by this paper
• Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells.

  2004cited by this paper
• Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract.

  2004cited by this paper
• Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.

  2004cited by this paper
• N-Cadherin Is Regulated by Activin A and Associated with Tumor Aggressiveness in Esophageal Carcinoma

  2004cited by this paper
• Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines.

  2004cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan

  2003cited by this paper
• Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization

  2003cited by this paper
• Overexpression of activin A in stage IV colorectal cancer

  2001cited by this paper
• Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.

  2001cited by this paper
• Activator Protein-1 Mediates Induced but not Basal Epidermal Growth Factor Receptor Gene Expression

  2000cited by this paper
• Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β

  1999cited by this paper
• Transcriptional activation of the human epidermal growth factor receptor promoter by human p53

  1996cited by this paper
• T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.

  1985cited by this paper
• Mithramycin therapy in disseminated germinal testicular cancer.

  1968cited by this paper
• Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells

  year unknowncited by this paper

• Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner

  2025cites this paper
• Activin A enhances neurofunctional recovery following traumatic spinal cord injury by inhibiting autophagy.

  2025cites this paper
• Dysregulated PI3K/AKT signaling in oral squamous cell carcinoma: The tumor microenvironment and epigenetic modifiers as key drivers

  2025cites this paper
• The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence

  2024cites this paper
• Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection

  2024cites this paper
• Dihydromyrcenol Modulates Involucrin Expression through the Akt Signaling Pathway

  2024cites this paper
• Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality

  2023cites this paper
• Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis

  2023cites this paper
• Identification of multidrug chemoresistant genes in head and neck squamous cell carcinoma cells

  2023cites this paper
• Exploration the role of INHBA in Hu sheep granulosa cells using RNA-Seq.

  2022cites this paper
• INHBA is a Prognostic Biomarker and Correlated With Immune Cell Infiltration in Cervical Cancer

  2022cites this paper
• UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway

  2022cites this paper
• Evolution of the ErbB gene family and analysis of regulators of Egfr expression during development of the rat spinal cord

  2022cites this paper
• Comprehensive analysis of INHBA: A biomarker for anti-TGFβ treatment in head and neck cancer

  2022cites this paper
• Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers

  2022cites this paper
• Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.

  2020cites this paper
• Novel biomarkers for subtle myocardial involvement in type I diabetes mellitus

  2020cites this paper
• Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns

  2020cites this paper
• Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma

  2020cites this paper